North American Vaccine (NVX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine (NVX)

NVX 1.035

-5.5%

Dec 30 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kech who wrote (30)	2/4/1997 10:47:00 AM
From: Don W Stone	of 35

To All:MAJOR NEWS: NVX announced that clinical trial shows promising results in development of new meningitis vaccine. Complete phase I trials. Just another significant piece of that pipeline we have been talking about here. The mind set that NVX is a one product company is a major misconception if you are trying to evaluate NVX as a long term investment IMO. The real value of NVX is indeed in the pipeline as it is also with most successful drug companies. Most of tomorrows revenue projections of any of the major drug companies are based on their pipeline. I do not hestitate to venture a guess that the "present value" of NVX's pipeline is conceivably on the order of 2 to 3 times todays market cap. I am indeed bias, very bias and I think for good reason. :-}

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next